TY - JOUR
T1 - Clinical evaluation of a (1,3)-β-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients
AU - Del Bono, Valerio
AU - Mularoni, Alessandra
AU - Furfaro, Elisa
AU - Delfino, Emanuele
AU - Rosasco, Lorenzo
AU - Miletich, Franca
AU - Viscoli, Claudio
PY - 2009/10
Y1 - 2009/10
N2 - (1,3)-β-D-Glucan (BG) is a component of the Pneumocystis jiroveci cell wall. Thirty-one immunocompromised patients with pneumonia (16 with presumptive pneumocystis pneumonia [PCP] and 15 with non-PCP) were evaluated for serum BG levels. Serum from all 16 presumptive PCP patients and from 2/15 patients with non-PCP was positive for BG. Results indicate that BG is a reliable marker for diagnosing PCP.
AB - (1,3)-β-D-Glucan (BG) is a component of the Pneumocystis jiroveci cell wall. Thirty-one immunocompromised patients with pneumonia (16 with presumptive pneumocystis pneumonia [PCP] and 15 with non-PCP) were evaluated for serum BG levels. Serum from all 16 presumptive PCP patients and from 2/15 patients with non-PCP was positive for BG. Results indicate that BG is a reliable marker for diagnosing PCP.
UR - http://www.scopus.com/inward/record.url?scp=70349696878&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70349696878&partnerID=8YFLogxK
U2 - 10.1128/CVI.00276-09
DO - 10.1128/CVI.00276-09
M3 - Article
C2 - 19692624
AN - SCOPUS:70349696878
VL - 16
SP - 1524
EP - 1526
JO - Clinical and Vaccine Immunology
JF - Clinical and Vaccine Immunology
SN - 1556-6811
IS - 10
ER -